199 related articles for article (PubMed ID: 20694513)
1. MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker.
Giaginis C; Giagini A; Tsourouflis G; Gatzidou E; Agapitos E; Kouraklis G; Theocharis S
Dig Dis Sci; 2011 Mar; 56(3):777-85. PubMed ID: 20694513
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.
Giaginis C; Georgiadou M; Dimakopoulou K; Tsourouflis G; Gatzidou E; Kouraklis G; Theocharis S
Dig Dis Sci; 2009 Feb; 54(2):282-91. PubMed ID: 18465232
[TBL] [Abstract][Full Text] [Related]
3. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.
Giaginis CT; Vgenopoulou S; Tsourouflis GS; Politi EN; Kouraklis GP; Theocharis SE
Pathol Oncol Res; 2009 Jun; 15(2):173-81. PubMed ID: 18987997
[TBL] [Abstract][Full Text] [Related]
5. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.
Shomori K; Nishihara K; Tamura T; Tatebe S; Horie Y; Nosaka K; Haruki T; Hamamoto Y; Shiomi T; Nakabayashi M; Ito H
Gastric Cancer; 2010 Aug; 13(3):177-85. PubMed ID: 20820987
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
Wojnar A; Kobierzycki C; Krolicka A; Pula B; Podhorska-Okolow M; Dziegiel P
Folia Histochem Cytobiol; 2010 Sep; 48(3):442-6. PubMed ID: 21097442
[TBL] [Abstract][Full Text] [Related]
9. Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications.
Gakiopoulou H; Korkolopoulou P; Levidou G; Thymara I; Saetta A; Piperi C; Givalos N; Vassilopoulos I; Ventouri K; Tsenga A; Bamias A; Dimopoulos MA; Agapitos E; Patsouris E
Br J Cancer; 2007 Oct; 97(8):1124-34. PubMed ID: 17940502
[TBL] [Abstract][Full Text] [Related]
10. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
11. The expression of MCM-2 in invasive breast carcinoma: a stereologic approach.
Cobanoglu U; Mungan S; Gundogdu C; Ersoz S; Ozoran Y; Aydin F
Bratisl Lek Listy; 2010; 111(1):45-9. PubMed ID: 20429312
[TBL] [Abstract][Full Text] [Related]
12. Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIalpha and Ki-67) in cavital fluid cytology: can we differentiate reactive mesothelial cells from malignant cells?
Kimura F; Kawamura J; Watanabe J; Kamoshida S; Kawai K; Okayasu I; Kuwao S
Diagn Cytopathol; 2010 Mar; 38(3):161-7. PubMed ID: 19821496
[TBL] [Abstract][Full Text] [Related]
13. Minichromosome Maintenance Proteins MCM-3, MCM-5, MCM-7, and Ki-67 as Proliferative Markers in Adrenocortical Tumors.
Aporowicz M; Czopnik P; Kubicka E; Piotrowska A; Dziegiel P; Bolanowski M; Domoslawski P
Anticancer Res; 2019 Mar; 39(3):1151-1159. PubMed ID: 30842144
[TBL] [Abstract][Full Text] [Related]
14. Increased RCAS1 expression is associated with advanced histopathological stage and poor prognosis in patients with gastric adenocarcinoma.
Giaginis C; Efkarpidis T; Alexandrou P; Patsouris E; Kouraklis G; Theocharis S
Dis Markers; 2013; 35(4):213-9. PubMed ID: 24167369
[TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
16. Replication protein A in nonearly ovarian adenocarcinomas: correlation with MCM-2, MCM-5, Ki-67 index and prognostic significance.
Levidou G; Ventouri K; Nonni A; Gakiopoulou H; Bamias A; Sotiropoulou M; Papaspirou I; Dimopoulos MA; Patsouris E; Korkolopoulou P
Int J Gynecol Pathol; 2012 Jul; 31(4):319-27. PubMed ID: 22653344
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa.
Going JJ; Keith WN; Neilson L; Stoeber K; Stuart RC; Williams GH
Gut; 2002 Mar; 50(3):373-7. PubMed ID: 11839717
[TBL] [Abstract][Full Text] [Related]
19. MCM proteins as diagnostic and prognostic tumor markers in the clinical setting.
Giaginis C; Vgenopoulou S; Vielh P; Theocharis S
Histol Histopathol; 2010 Mar; 25(3):351-70. PubMed ID: 20054807
[TBL] [Abstract][Full Text] [Related]
20. The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study.
Ahadi M; Moradi A; Musavinejad L; Movafagh A; Moradi A
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1607-1614. PubMed ID: 32592354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
